SBSP

Space-Based Solar Power Market worth $6.8 billion by 2040 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, February 27, 2024
Lithium, Hydrogen, Mass, Space-based solar power, Traction, End user, GEO, Solar Power, Satellite, Satellite bus, Dual, Thales Alenia Space, Thruster, Government, Urbanization, Commercial, Rocket, OHB, SBSP, Grumman, MEO, Statistics, Solar panel, Small satellite, Workforce, Graphene, LEO, CubeSat, Component, Communications satellite

By end users, the Space-Based Solar Power market for the government and defense segment is projected to grow at the highest market share during the forecast period.

Key Points: 
  • By end users, the Space-Based Solar Power market for the government and defense segment is projected to grow at the highest market share during the forecast period.
  • The government and defense segment in Space-Based Solar Power is thriving due to defense agencies recognizing the strategic advantages of Space-Based Solar Power, offering reliable and independent power sources for critical installations and military operations, especially in remote or hostile environments.
  • The dual-use nature of Space-Based Solar Power technologies presents opportunities for synergies between civilian and military applications, encouraging government funding and collaboration.
  • The Asia-Pacific region boasts a skilled workforce, advanced manufacturing capabilities, and a burgeoning space industry ecosystem, fostering innovation and cost-effective deployment of Space-Based Solar Power systems.

Space-Based Solar Power Market worth $6.8 billion by 2040 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, February 27, 2024
Lithium, Hydrogen, Mass, Space-based solar power, Traction, End user, GEO, Solar Power, Satellite, Satellite bus, Dual, Thales Alenia Space, Thruster, Government, Urbanization, Commercial, Rocket, OHB, SBSP, Grumman, MEO, Statistics, Solar panel, Small satellite, Workforce, Graphene, LEO, CubeSat, Component, Communications satellite

By end users, the Space-Based Solar Power market for the government and defense segment is projected to grow at the highest market share during the forecast period.

Key Points: 
  • By end users, the Space-Based Solar Power market for the government and defense segment is projected to grow at the highest market share during the forecast period.
  • The government and defense segment in Space-Based Solar Power is thriving due to defense agencies recognizing the strategic advantages of Space-Based Solar Power, offering reliable and independent power sources for critical installations and military operations, especially in remote or hostile environments.
  • The dual-use nature of Space-Based Solar Power technologies presents opportunities for synergies between civilian and military applications, encouraging government funding and collaboration.
  • The Asia-Pacific region boasts a skilled workforce, advanced manufacturing capabilities, and a burgeoning space industry ecosystem, fostering innovation and cost-effective deployment of Space-Based Solar Power systems.

Global Space-Based Solar Power Market Share Revenue Envisaged to Reach USD 1,108.90 Million by 2032, at 8.0% CAGR: Polaris Market Research

Retrieved on: 
Wednesday, October 11, 2023
Northrop, SBSP, Investment, Application, Report, Space-based solar power, Microwave, R, Solar energy, Growth, Grumman, Detail, California Institute for Telecommunications and Information Technology, California Institute of Technology, Orbit, Research, Renewable energy, Communications satellite, Electricity

Satellites need electricity to power their scientific instruments, communication systems, navigation systems, and data collection systems, among other things.

Key Points: 
  • Satellites need electricity to power their scientific instruments, communication systems, navigation systems, and data collection systems, among other things.
  • North America: Within the region, the United States has emerged as a significant market for solar energy generated in space.
  • What is the current and expected space based solar power market size during the forecast period?
  • What factors are driving the space based solar power market growth?

Spinal Resources Inc. Unveils Groundbreaking Spine Platform for Improved Patient Care

Retrieved on: 
Tuesday, April 4, 2023
Elective surgery, Spinal fusion, Spine, Surgeon, Mischer Neuroscience Institute, Failure, Screw, Physiology, Head, Swaging, SBSP, Incidence, ASD, Orthopedic surgery, Johns Hopkins, FDA, PJF, Bézier, Deformity, SRI, Medical device, Rolling (metalworking), Extrusion

FORT LAUDERDALE, Fla., April 4, 2023 /PRNewswire-PRWeb/ -- Spinal Resources Inc. (SRI), a leading innovator in spinal technology, has announced the FDA-approval of its state-of-the-art, Solutions Based Spine Platform (SBSP). The unique platform is designed to provide surgeons with an unparalleled solution to address and assist in the reduction of critical spinal conditions like Proximal Junctional Kyphosis (PJK), Proximal Junctional Failure (PJF), and Adjacent Segment Disease (ASD).

Key Points: 
  • FORT LAUDERDALE, Fla., April 4, 2023 /PRNewswire-PRWeb/ -- Spinal Resources Inc. (SRI), a leading innovator in spinal technology, has announced the FDA-approval of its state-of-the-art, Solutions Based Spine Platform (SBSP).
  • The Solutions Based Spine Platform features a novel screw cap interface that toggles between a polyaxial and monoaxial head.
  • The platform offers a robust, biomechanically sound, and innovative approach to spinal care, leveraging our unique rod system and cutting-edge AI technology.
  • For more information about Spinal Resources Inc. and its Solutions Based Spine Platform, please visit http://spinalresourcesinc.com/ or contact the media relations team.

Fosun Pharma and MAIA Pharmaceuticals Jointly Announce the Successful Commercialization of Only FDA Approved 20ml Sodium Phenylacetate and Sodium Benzoate (SPSB) Liquid Product

Retrieved on: 
Monday, September 26, 2022
Central nervous system, Immunomodulation, ADC, FDA, Fosun Pharma, Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., Integration, SBSP, Senior, Partnership, Metabolism, MAIA, Human, Hormone, HK, General manager, Sodium benzoate, RNA, PROTAC, Research, Steroid, Internationalization, Innovation, Fine chemical, Online shopping, Generic

PRINCETON, N.J., Sept. 26, 2022 /PRNewswire/ -- Shanghai Fosun Pharma (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced that the 20 ml, Sodium Phenylacetate and Sodium Benzoate (SPSB) liquid product, which is under an exclusive partnership between Fosun Pharma USA Inc. ("Fosun Pharma USA"), the US-based subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.

Key Points: 
  • PRINCETON, N.J., Sept. 26, 2022 /PRNewswire/ -- Shanghai Fosun Pharma (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced that the 20 ml, Sodium Phenylacetate and Sodium Benzoate (SPSB) liquid product, which is under an exclusive partnership between Fosun Pharma USA Inc. ("Fosun Pharma USA"), the US-based subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.
  • HK) and MAIA Pharmaceuticals, Inc. (MAIA), a Princeton, NJ based specialty pharmaceutical company, has been recently launched.
  • Fosun Pharma USA has the exclusive commercial rights of this product in the U.S. market.
  • For Fosun Pharma USA, this is the first of many 505(b)(2) that will be launched over the next few years."

Philips PACS interoperability helps Scotland’s National Health Service deliver leading breast cancer screening

Retrieved on: 
Wednesday, March 16, 2022
Mammography, Informatics, Global, Philips, National Health Service, Solution, AEX, Technology, Breast cancer, NHS Scotland, PACS, Patient, PMID, Partnership, Hospital, Public Health Scotland, NHS National Services Scotland, PHS, COVID-19, Diagnosis, PHG, NHS, Health, Woman, Cancer, Vue, NYSE, SBSP, INT, Female, Image, Time-invariant system, Disease, Picture archiving and communication system, Medical imaging, Medicine

Philips vendor-neutral Vue PACS (Picture Archiving and Communication System) allows the SBSPs six breast screening centers and its mobile screening units to interoperate with Scotlands national PACS system, increasing access to breast screening for Scotlands rural communities, enhancing patient choice, and streamlining diagnostic and treatment workflows.

Key Points: 
  • Philips vendor-neutral Vue PACS (Picture Archiving and Communication System) allows the SBSPs six breast screening centers and its mobile screening units to interoperate with Scotlands national PACS system, increasing access to breast screening for Scotlands rural communities, enhancing patient choice, and streamlining diagnostic and treatment workflows.
  • Female breast cancer is the worlds most common form of cancer, with approximately 2.26 million new cases in 2020 [1].
  • Through the partnership between Philips and NHS National Services Scotland, as many as 270,000 women in Scotland between the ages of 50 and 70 are invited for breast screening (mammography) every year [3].
  • The interoperability of Philips Vue PACS has been a key factor in reducing that backlog, offering enhanced connectivity between the screening programs regional screening centers, as well as interoperability with Scotlands Global PACS system.